Teknova
Private Company
Total funding raised: $40M
Overview
Teknova is a specialized reagent manufacturer providing critical consumables to the biotech, diagnostics, and therapeutic development sectors. With nearly three decades of operation, the company leverages its ISO 13485-certified facilities to offer over 1,400 ready-to-ship products and extensive custom manufacturing services, emphasizing flexibility, quality, and speed. Its business model is built on supporting customers from research through clinical manufacturing, helping to streamline scale-up and tech transfer processes. Teknova's strategic positioning in high-growth areas like cell and gene therapy and synthetic biology underpins its market opportunity.
Technology Platform
Modular, scalable manufacturing infrastructure for RUO and GMP-grade liquid and solid reagents, with expertise in custom formulation, flexible formatting (tubes to single-use bags), and rigorous QC testing. Specialized systems for cryopreservation (PluriFreeze) and AAV production (AAV•Tek).
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Competes with large, diversified life science suppliers (e.g., Thermo Fisher Scientific, Merck KGaA, Danaher) and smaller niche reagent manufacturers. Differentiation is achieved through high-touch custom services, rapid turnaround times, a focus on flexible formatting, and targeted expertise in areas like cell therapy and synthetic biology.